Summit Therapeutics (SMMT) null Earnings

15NovConfirmed
May 21
Aug 21
Q2 2021
Nov 21
-1.35
-0.96
-0.56
-0.17

Details

Expected EPS
-0.29
Actual EPS
-1
Surprise EPS
-0.71
Surprise Percent
+244.83%

Description

Summit Therapeutics (SMMT) has reported earnings of -1 per share for .

0 Comments

Share your thoughts